ReviewInnere Medizin (Heidelberg, Germany)2025
[Transition in patients with congenital heart disease].
Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital heart defects are the most common singular congenital organ malformation. Due to advances in medical care, more than 95% of affected persons now reach adulthood. However, congenital heart defects are often associated with residuals or sequelae that require lifelong specialized care. Lack of or irregular follow-up care leads to worse outcomes. Nevertheless, follow-up care for adults with congenital heart disease (ACHD) is still often inconsistent in reality, and many patients receive care outside of qualified structures.The transition process-the shift from pediatric to adult medical care-is critical. Many affected individuals experience little to no subjective limitations at this stage. Nevertheless, they must gradually take responsibility for their health while adapting to an unfamiliar healthcare provider.A structured transition process aims to improve continuity of care, promote disease acceptance, and prevent gaps in medical care. Both, patients and their primary care providers must be well-informed and aware of specialized care structures. Interdisciplinary collaboration among primary care providers, pediatric and ACHD specialists, and adult cardiologists is essential and should be supported by transition programs or patient organizations.Failure in the transition process primarily puts at risk the health of affected individuals but can also unnecessarily strain the healthcare system. A successful transition and a comprehensive, specialized care network are key to sustainably improving the prognosis of ACHD patients.
Indexed as
Identifiers
40387869What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.